May 24, 2017 10:35 AM ET

Pharmaceuticals

Company Overview of MOTUS THERAPEUTICS, INC.

Key Executives for MOTUS THERAPEUTICS, INC.

NameBoard RelationshipsTitleAge
Keith Michael Gottesdiener M.D.27 RelationshipsChief Executive Officer and Director62
Bart Henderson MBANo RelationshipsFounder and President57
Elizabeth Stoner M.D., M.S.43 RelationshipsFounder and Member of Scientific Advisory Board66
Fred T. Fiedorek M.D.No RelationshipsChief Medical Officer--
Lex H.T. van der Ploeg Ph.D.36 RelationshipsChief Scientific Officer61

MOTUS THERAPEUTICS, INC. Board Members*

NameBoard RelationshipsPrimary CompanyAge
David P. Meeker M.D. 20 RelationshipsSanofi62
Keith Michael Gottesdiener M.D. 27 RelationshipsRhythm Holding Company, LLC62
Elizabeth Stoner M.D., M.S. 43 RelationshipsRhythm Holding Company, LLC66
Lee M. Kaplan M.D., Ph.D. 100 RelationshipsZafgen, Inc.--
Todd Foley MBA 43 RelationshipsMPM Capital44
View All Board Members

MOTUS THERAPEUTICS, INC. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., Ph.D.Lee M. Kaplan100 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
369.1K
Bonus
400.1K
Total Short Term Compensation
517.5K
Total Value of Options
9.1M
Compensation as of Fiscal Year
MOTUS THERAPEUTICS, INC. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Pacira Pharmaceuticals, Inc. Announces Resignation of James Scibetta as President, Effective from June 30, 2017
May 23, 2017 8:30 PM ET
Sichuan Languang Development Co., Ltd. Approves the Appointment of Wang Wanfeng as Executive Vice President
May 23, 2017 11:01 AM ET
Hainan Haiyao Co., Ltd. Approves Dividend for 2016; Approves the Election of Directors
May 22, 2017 3:32 PM ET
Claris Lifesciences Limited Announces Board Changes
May 20, 2017 7:18 AM ET
Hunan Hansen Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2016; Elects Board Members; Approves Amendments to the Company's Articles of Association
May 19, 2017 3:34 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MOTUS THERAPEUTICS, INC., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.